Radiotherapy & Oncology
Volume 93, Issue 2 , Pages 241-245, November 2009

MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: The feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence

  • Tobias Franiel

      Affiliations

    • Department of Radiology, Charité – Universitätsmedizin Berlin, Germany
    • Corresponding Author InformationCorresponding author. Address: Department of Radiology, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
    • ,
  • Lutz Lüdemann

      Affiliations

    • Department of Radiotherapy, Charité – Universitätsmedizin Berlin, Germany
    • ,
  • Matthias Taupitz

      Affiliations

    • Department of Radiology, Charité – Universitätsmedizin Berlin, Germany
    • ,
  • Dirk Böhmer

      Affiliations

    • Department of Radiotherapy, Charité – Universitätsmedizin Berlin, Germany
    • ,
  • Dirk Beyersdorff

      Affiliations

    • Department of Radiology, Charité – Universitätsmedizin Berlin, Germany

Received 8 August 2008; received in revised form 31 July 2009; accepted 11 August 2009. published online 14 September 2009.

Abstract 

Purpose

To identify and quantify suitable pharmacokinetic MRI parameters for monitoring tissue changes after external beam intensity-modulated radiotherapy of prostate cancer.

Material and methods

Six patients with biopsy-proven prostate cancer (initial PSA, 6.0–81.4ng/ml) underwent MRI at 1.5T using a combined endorectal/body phased-array coil and a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence (T1/T2∗w; 1.65s temporal resolution). MRI was performed before and immediately after radiotherapy, at 3months and at 1year. Perfusion, blood volume, mean transit time, delay, dispersion, interstitial volume, and extraction coefficient were calculated in prostate cancer and normal prostate for all four time points using a sequential 3-compartment model.

Results

Prostate cancer and normal prostate tissue showed a statistically significant decrease in perfusion (p=0.006, p=0.001) and increase in extraction coefficient (p=0.004, p<0.001). For prostate cancer, there was also a decrease in vascular volume (p=0.034). The other parameters investigated showed no statistically significant changes. Statistically significant differences between prostate cancer and normal prostate tissue were only observed before radiotherapy, when prostate cancer showed significantly higher perfusion (1.84 vs. 0.12ml/cm3min, p=0.028) and a smaller extraction coefficient (0.42 vs. 0.64, p=0.028).

Conclusions

Two pharmacokinetic parameters, perfusion and extraction coefficient, appear to be suitable candidates for monitoring the response to percutaneous intensity-modulated radiotherapy of prostate cancer.

Keywords: Prostate cancer, Pharmacokinetic magnetic resonance imaging, Dynamic contrast enhanced magnetic resonance imaging, External beam intensity-modulated radiotherapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(09)00442-3

doi:10.1016/j.radonc.2009.08.016

Radiotherapy & Oncology
Volume 93, Issue 2 , Pages 241-245, November 2009

Article Tools

* Image Usage & Resolution